AR073047A1 - Derivados de imidazol - Google Patents
Derivados de imidazolInfo
- Publication number
- AR073047A1 AR073047A1 ARP090103196A ARP090103196A AR073047A1 AR 073047 A1 AR073047 A1 AR 073047A1 AR P090103196 A ARP090103196 A AR P090103196A AR P090103196 A ARP090103196 A AR P090103196A AR 073047 A1 AR073047 A1 AR 073047A1
- Authority
- AR
- Argentina
- Prior art keywords
- heterocyclyl
- carbocyclyl
- alkyl
- optionally substituted
- opportunity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9012208P | 2008-08-19 | 2008-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR073047A1 true AR073047A1 (es) | 2010-10-06 |
Family
ID=41226923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090103196A AR073047A1 (es) | 2008-08-19 | 2009-08-19 | Derivados de imidazol |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR073047A1 (zh) |
TW (1) | TW201011017A (zh) |
UY (1) | UY32055A (zh) |
WO (1) | WO2010020810A1 (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2554544A1 (en) * | 2011-08-01 | 2013-02-06 | Almirall, S.A. | Pyridin-2(1h)-one derivatives as jak inhibitors |
US20160123982A1 (en) | 2013-02-04 | 2016-05-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for assaying jak2 activity in red blood cells and uses thereof |
EP3359154B1 (en) * | 2015-10-08 | 2021-05-26 | Suzhou Yunxuan Yiyao Keji Youxian Gongsi | Wnt signaling pathway inhibitors and therapeutic applications thereof |
PE20190971A1 (es) | 2016-06-13 | 2019-07-09 | Glaxosmithkline Ip Dev Ltd | Compuestos quimicos |
KR20190026902A (ko) | 2016-07-14 | 2019-03-13 | 화이자 인코포레이티드 | 바닌-1 효소의 억제제로서의 신규 피리미딘 카르복스아미드 |
WO2018167283A1 (en) | 2017-03-17 | 2018-09-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the diagnosis and treatment of pancreatic ductal adenocarcinoma associated neural remodeling |
WO2018189335A1 (en) | 2017-04-13 | 2018-10-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the diagnosis and treatment of pancreatic ductal adenocarcinoma |
WO2020092015A1 (en) | 2018-11-02 | 2020-05-07 | University Of Rochester | Therapeutic mitigation of epithelial infection |
CN112094227B (zh) * | 2020-05-29 | 2021-04-16 | 凯美克(上海)医药科技有限公司 | 一种1-(5-氯-3-氟吡啶-2-基)乙胺的合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2375735T3 (es) * | 2005-02-04 | 2012-03-05 | Astrazeneca Ab | Derivados de pirazolilaminopiridina útiles como inhibidores de quinasas. |
WO2007031745A1 (en) * | 2005-09-16 | 2007-03-22 | Astrazeneca Ab | Pyrimidine derivatives for the inhibition of igf-ir tyrosine kinase activity |
EP2388259A1 (en) * | 2005-10-28 | 2011-11-23 | AstraZeneca AB | 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
WO2008117050A1 (en) * | 2007-03-27 | 2008-10-02 | Astrazeneca Ab | Pyrazolyl-amino-substituted pyrazines and their use for the treatment of cancer |
-
2009
- 2009-08-18 TW TW098127738A patent/TW201011017A/zh unknown
- 2009-08-18 UY UY0001032055A patent/UY32055A/es unknown
- 2009-08-18 WO PCT/GB2009/051032 patent/WO2010020810A1/en active Application Filing
- 2009-08-19 AR ARP090103196A patent/AR073047A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW201011017A (en) | 2010-03-16 |
UY32055A (es) | 2010-03-26 |
WO2010020810A1 (en) | 2010-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR073047A1 (es) | Derivados de imidazol | |
AR073327A1 (es) | Heterociclos nitrogenados y su uso como anticancerigenos | |
AR069899A1 (es) | Compuestos quimicos derivados de pirazol-triazina | |
PE20141066A1 (es) | Compuestos de benzotiazol | |
AR066147A1 (es) | Pirazol-pirimidinas, composicion farmaceutica, proceso y uso en trastornos mieloproliferativos, sindrome mielodisplasico y cancer | |
CO6541645A2 (es) | Compuestos de indol y su uso farmaceutico | |
AR076900A1 (es) | Derivados heterociclicos nitrogenados utiles como agentes antivirales, composiciones farmaceuticas que los contienen y uso de los mismos como inhibidores del vhc | |
AR055076A1 (es) | Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica. | |
PH12015502534A1 (en) | Benzimidazole derivatives as bromodomain inhibitors | |
CR20150401A (es) | Formas de rifaximina y sus usos | |
PE20141182A1 (es) | Derivados fusionados de aminodihidrotiazina | |
EA201170922A1 (ru) | Производные сульфонамида | |
CO6741203A2 (es) | Derivados de biciclo[3,2,1]octilamida y sus usos | |
EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
CU20110235A7 (es) | Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17 | |
HN2012000263A (es) | Derivados n1-sulfonil-5-fluoropirimidinona | |
AR053334A1 (es) | Pirazolilcarboxanilidas | |
SV2011004077A (es) | Derivados aminobutiricos sustituidos como inhibidores de neprilisina | |
CR8756A (es) | Derivados de acido carboxilico bencimidazolona | |
AR063101A1 (es) | Derivados de pirazina-2-carboxiamida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento o profilaxis de enfermedades asociadas con la modulacion de receptores del cb2. | |
UY30082A1 (es) | Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos | |
SV2006002232A (es) | Inhibidores bace ref. x-16940 | |
CR20140294A (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
AR066429A1 (es) | Derivados de imidazolopiridina y purina como inhibidores de tirosina quinasa | |
SV2011003997A (es) | Pirimidinas fusionadas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |